戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 on through the transient placement of a 5-Fr vascular catheter.
2 lly wrapped around the proximal segment of a vascular catheter.
3 ally prepared under general anaesthesia with vascular catheters.
4 y justifying the continued use of multilumen vascular catheters.
5 -Dawley rats weighing 275-425 g with chronic vascular catheters.
6 ts were instrumented with a tracheostomy and vascular catheters.
7 zed and instrumented with a tracheostomy and vascular catheters.
8 es were continuously monitored by indwelling vascular catheters.
9 zed and instrumented with a tracheostomy and vascular catheters.
10 ed on 42-h-fasted conscious dogs fitted with vascular catheters.
11 nal age) were instrumented with amniotic and vascular catheters, an electrocardiogram (ECG) electrode
12 on (term ca 145 days) were instrumented with vascular catheters and a femoral artery Transonic flow p
13 n (dGA; term is approximately 145 days) with vascular catheters and a Transonic flow probe around a f
14 ally prepared under general anaesthesia with vascular catheters and a Transonic flow probe positioned
15 d between 117 and 120 days of gestation with vascular catheters and an umbilical flow probe.
16      Rats were instrumented chronically with vascular catheters and bilateral guide cannulae directed
17 their singleton fetus were instrumented with vascular catheters and flow probes around an umbilical a
18 groups of conscious dogs fitted with chronic vascular catheters and intracerebroventricular (i.c.v.)
19 ion under general halothane anaesthesia with vascular catheters and transit-time ultrasonic flow prob
20 heep at 0.8 gestation were instrumented with vascular catheters and Transonic flow probes around an u
21 tion (term is ca 145 days) with amniotic and vascular catheters and with a transit-time flow probe ar
22 tion (term is ca 145 days) with amniotic and vascular catheters and with a transit-time flow probe ar
23 und the umbilical cord, amniotic and femoral vascular catheters and with transit-time flow probes aro
24 Candida cells adhere to a surface, such as a vascular catheter, and become encased in an extracellula
25                                 Many central vascular catheters (CVCs) are removed unnecessarily beca
26 dida albicans biofilms, including those from vascular catheter, denture, and urinary catheter models
27                                     Silicone vascular catheters have a greater risk of infection and
28 ed in the parasagittal parietal cortices and vascular catheters in the sagittal sinus and brachioceph
29 sor-masked randomized trial in patients with vascular catheters inserted for an expected duration of
30 e of culturing a single segment of a central vascular catheter is inadequate and needs to be reexamin
31 infection were nasal carriage, presence of a vascular catheter, low CD4 count, and neutropenia.
32 hetized and mechanically ventilated, and had vascular catheters placed.
33 er complement activation in vitro than other vascular catheter polymer materials.
34 le drapes was measured, and surveillance for vascular catheter-related infection was performed.
35 on termed the dorsal vagal complex (DVC) and vascular catheters to enable direct DVC infusion and blo
36 orsal margin of the CeA in male Wistar rats; vascular catheters were also placed at this time.
37                     Patients with indwelling vascular catheters were excluded.
38      Crown-rump length-measuring devices and vascular catheters were implanted in 12 sheep fetuses at
39                   Under general anaesthesia, vascular catheters were inserted and a Transonic flow pr
40  a history of multiple infections of central vascular catheters with other organisms, requiring cours

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。